NCT06121427View on ClinicalTrials.gov

Incidence of Viral Hepatitis D Relapses Upon Discontinuation of Bulevirtide in Patients With Chronic Hepatitis D and Negative HDV RNA

CompletedOBSERVATIONAL

Enrollment

24

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions

Chronic Hepatitis D

Trial Locations (1)

125008

Center of Target Therapy, Moscow

All Listed Sponsors

lead

Center of target therapy

OTHER